broker briefing., page-7

"Weaknesses:
None of any note that XanaX can think of."

That is the kind of real-world analysis that the 'experts' should write, but they never do.

Being devil's advocate I have tried to think of any weakness. The only one that I can think of, - and its more an unknown than a weakness, - is the ability or otherwise of the company's PR machine to sell it to the stock market. In other words, to make it a sexy headline story.

Novices will dismiss this as nonsense, but older hands will tick it as the number one priority.

Even the best story will not sell itself, and many a great story has foundered for want of 'selling', so I just hope these guys allocate enough resources to keep it in front of the people who will make or break it. That's us.